Galactosylated poly(ethylene glycol)-b-poly (l-lactide-co-β-malic acid) block copolymer micelles for targeted drug delivery: Preparation and in vitro characterization

International Journal of Nanomedicine

Volumn 5, Issue 1, 2010, Pages 1029-1038

  Suo, Aili ^a   Qian, Junmin ^a   Yao, Yu ^a   Zhang, Wanggang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Chemotherapy; Doxorubicin; Hepatocellular carcinoma; Polymer micelles; Targeted drug delivery

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; COPOLYMER; DOXORUBICIN; DRUG CARRIER; GALACTOSE; MACROGOL; MALIC ACID; POLY(LACTIC ACID CO MALIC ACID); UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; DRUG DERIVATIVE; MACROGOL DERIVATIVE; MALIC ACID DERIVATIVE; POLY(L LACTIDE CO BETA MALIC ACID); POLY(L-LACTIDE-CO-BETA-MALIC ACID); POLYESTER;

ARTICLE; CELL CYCLE ARREST; CELL CYCLE S PHASE; CELL STRAIN HEPG2; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG MECHANISM; DRUG RELEASE; DRUG TARGETING; ENDOCYTOSIS; FLOW CYTOMETRY; IN VITRO STUDY; LIGHT SCATTERING; MICELLE; PH MEASUREMENT; TRANSMISSION ELECTRON MICROSCOPY; ANALYSIS OF VARIANCE; CELL CYCLE; CELL SURVIVAL; CHEMISTRY; CONFOCAL MICROSCOPY; DRUG EFFECT; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; PH;

ANALYSIS OF VARIANCE; ANTIBIOTICS, ANTINEOPLASTIC; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL SURVIVAL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; GALACTOSE; HEP G2 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; LIVER NEOPLASMS; MALATES; MICELLES; MICROSCOPY, CONFOCAL; POLYESTERS; POLYETHYLENE GLYCOLS;

EID: 79954493692     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S14280     Document Type: Article

References (29)

1. Yang XL, Zou P, Yao J, et al. Proteomic dissection of cell type-specific H2AX-interacting protein complex associated with hepatocellular carcinoma. J Proteome Res. 2010;9:1402-1415.
2. Huynh H. Molecularly targeted therapy in hepatocellular carcinoma. Biochem Pharmacol. 2010;80:550-560.
3. Xu ZH, Chen LL, Gu WW, et al. The performance of docetaxelloaded solid lipid nanoparticles targeted to hepatocellular carcinoma. Biomaterials. 2009;30:226-232.
4. Fiume L, Baglioni M, Bolondi L, Farina C, Stefano GD. Doxorubicin coupled to lactosaminated human albumin: A hepatocellular carcinoma targeted drug. Drug Discov Today. 2008;13:1002-1009.
5. Zhang J, Chen XG, Sun GZ, Huang L, Cheng XJ. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin. Colloids Surf B Biointerfaces. 2010;77:125-130.
6. Musacchio T, Toniutti M, Kautz R, Torchilin VP. 1H NMR detection of mobile lipids as a marker for apoptosis: The case of anticancer drug-loaded liposomes and polymeric micelles. Mol Pharm. 2009;6: 1876-1882.
7. ® series hyperbranched aliphatic polyester and folic acid. Polym Adv Technol. 2009; doi: 10.1002/pat.1535.
8. Kurtoglu YE, Mishra MK, Kannan S, Kannan RM. Drug release characteristics of PAMAM dendrimer-drug conjugates with different linkers. Int J Pharm. 2010;384:189-194.
9. Zerrin S, Nilufer Y, Tamer B. Investigation of pluronic and PEG-PE micelles as carriers of meso-tetraphenyl porphine for oral administration. Int J Pharm. 2007;332:161-167.
10. Chen W, Meng FH, Li F, Ji SJ, Zhong ZY. pH-responsive biodegradable micelles based on acid-labile polycarbonate hydrophobe: Synthesis and triggered drug release. Biomacromolecules. 2009;10:1727-1735.
11. Li XM, Ding LY, Xu YL, Wang YL, Ping QN. Targeted delivery of doxorubicin using stealth liposomes modified with transferring. Int J Pharm. 2009;373:116-123.
12. Zhang C, Gao SJ, Jiang W, et al. Targeted minicircle DNA delivery using folate-poly(ethyleneglycol)-polyethylenimine as non-viral carrier. Biomaterials. 2010;31:6075-6086.
13. Mei H, Shi W, Pang ZQ, et al. EGFP-EGF1 protein-conjugated PEGPLA nanoparticles for tissue factor targeted drug delivery. Biomaterials. 2010;31:5619-5626.
14. Prabaharan M, Grailer JJ, Pilla S, Steeber DA, Gong SQ. Amphiphilic multi-arm-block copolymer conjugated with doxorubicin via pH-sensitive hydrazone bond for tumor-targeted drug delivery. Biomaterials. 2009;30:5757-5766.
15. Patil Y, Sadhukha T, Ma L, Panyam J. Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance. J Control Release. 2009;136:21-29.
16. Kikkeri R, Lepenies B, Adibekian A, Laurino P, Seeberger PH. In vitro imaging and in vivo liver targeting with carbohydrate capped quantum dots. J Am Chem Soc. 2009;131:2110-2112.
17. Higuchi Y, Oka M, Kawakami S, Hashida M. Mannosylated semiconductor quantum dots for the labeling of macrophages. J Control Release. 2008;125:131-136.
18. Wang Z, Chui WK, Ho PC. Design of a multifunctional PLGA nanoparticulate drug delivery system: Evaluation of its physicochemical properties and anticancer activity to malignant cancer cells. Pharm Res. 2009;26:1162-1171.
19. Liu Y, Wang W, Wang J, et al. Blood compatibility evaluation of poly(d,llactide- co-beta-malic acid) modified with the GRGDS sequence. Colloids Surf B Biointerfaces. 2010;75:370-376.
20. He B, Poon YF, Feng J, Chan-Park MB. Synthesis and characterization of functionalized biodegradable poly(DL-lactide-co-RS-β-malic acid). J Biomed Mater Res. 2008;87A:254-263.
21. Wang L, Neoh KG, Kang ET, Shuter B, Wang SC. Biodegradable magnetic-fluorescent magnetite/poly(dl-lactic acid-co-α,β-malic acid) composite nanoparticles for stem cell labeling. Biomaterials. 2010;31: 3502-3511.
22. Coulembier O, Degée P, Barbaud C, Guérin P, Dubois P. New amphiphilic graft copolymer based on poly(β-malic acid): Synthesis and characterization. Polym Bull. 2004;51:365-372.
23. He B, Wan YQ, Bei JZ, Wang SG. Synthesis and cell affinity of functionalized poly(l-lactide-co-β-malic acid) with high molecular weight. Biomaterials. 2004;25:5239-5247.
24. Zerrin S, Nilufer Y, Tamer B. Preparation and characterization of polymeric micelles for solubilization of poorly soluble anticancer drugs. Eur J Pharm Biopharm. 2006;64:261-268.
25. Wang Y, Xin DC, Liu KJ, Zhu MQ, Xiang JN. Heparin-paclitaxel conjugates as drug delivery system: Synthesis, self-assembly property, drug release, and antitumor activity. Bioconjug Chem. 2009;20:2214-2221.
26. Hatakeyama H, Akita H, Maruyama K, Suhara T, Harashima H. Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo. Int J Pharm. 2004;281:25-33.
27. Kim HS, Lee YS, Kim DK. Doxorubicin exerts cytotoxic effects through cell cycle arrest and fas-mediated cell death. Pharmacology. 2009;84:300-309.
28. Wang Q, Zhang L, Hu W, et al. Norcantharidin-associated galactosylated chitosan nanoparticles for hepatocyte-targeted delivery. Nanomedicine. 2010;6:371-381.
29. Cao Y, Gu Y, Ma H, et al. Self-assembled nanoparticle drug delivery systems from galactosylated polysaccharide-doxorubicin conjugate loaded doxorubicin. Int J Biol Macromol. 2010;46:245-249.